Quantcast

Latest AbbVie Inc. Stories

2014-07-08 08:30:17

THIS DOES NOT CONSTITUTE AN ANNOUNCEMENT OF A FIRM INTENTION TO MAKE AN OFFER UNDER RULE 2.7 OF THE CITY CODE ON TAKEOVERS AND MERGERS (THE "CODE"). THERE CAN BE NO CERTAINTY THAT ANY FIRM OFFER WILL BE MADE NORTH CHICAGO, Ill., July 8, 2014 /PRNewswire/ -- Following the announcement on June 25, 2014, where AbbVie outlined its strong strategic rationale and commitment regarding a combination with Shire, AbbVie and its financial adviser have met with, or spoken to, a large number of Shire...

2014-06-25 12:30:34

DUBLIN, Ireland, June 25, 2014 /PRNewswire/ -- NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION (IN WHOLE OR IN PART) IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION. Shire plc ("Shire" or the "Company") (LSE: SHP, NASDAQ: SHPG) notes today's announcement by AbbVie Inc. ("AbbVie") repeating its proposal of May 30, 2014, which comprised GBP20.44 in cash and 0.7988...

2014-06-25 08:30:09

Supplementary information about AbbVie Inc. ("AbbVie") NORTH CHICAGO, Ill., June 25, 2014 /PRNewswire/ -- On June 25, 2014, AbbVie issued the following supplementary information about the company: -- AbbVie Facts at a Glance -- AbbVie Supplementary Information A copy of these materials will be available on AbbVie's website at: http://www.abbvieinvestor.com/phoenix.zhtml?c=251551&p=irol-disclaimer-documents In accordance with Rule 30.4 of the Takeover Code, a copy of this...

2014-06-20 04:20:44

DUBLIN, June 20, 2014 /PRNewswire/ -- NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION (IN WHOLE OR IN PART) IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION Shire plc ("Shire" or the "Company") (LSE: SHP, NASDAQ: SHPG) notes the announcement made by AbbVie Inc. ("AbbVie") and confirms that on 30 May 2014, Shire received an unsolicited and highly conditional...

2014-06-20 00:20:35

THIS IS AN ANNOUNCEMENT FALLING UNDER RULE 2.4 OF THE CITY CODE ON TAKEOVERS AND MERGERS (THE "CODE") AND DOES NOT CONSTITUTE AN ANNOUNCEMENT OF A FIRM INTENTION TO MAKE AN OFFER UNDER RULE 2.7 OF THE CODE. THERE CAN BE NO CERTAINTY THAT ANY FIRM OFFER WILL BE MADE LONDON, June 19, 2014 /PRNewswire/ -- AbbVie Inc. ("AbbVie") notes the recent press speculation and confirms it made an indicative approach to Shire plc ("Shire") with a merger proposal which was rejected by the Board of...

2014-06-18 23:16:15

Attorneys representing national Androgel testosterone lawsuits at The Onder Law Firm announce the launch of a new website, offering timely news updates, information, and no-cost testosterone lawsuit case review for persons seeking to file an Androgel lawsuit for heart attack or stroke. St. Louis, MO (PRWEB) June 18, 2014 The Androgel Testosterone Lawsuits website is a new resource from national product and family safety attorneys at The Onder Law Firm. Based in St. Louis, these...

2014-05-27 12:32:32

LONDON, May 27, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Global Diabetic Nephropathy Market 2014-2018http://www.reportbuyer.com/pharma_healthcare/diseases/global_diabetic_nephropathy_market_2014_2018.html About Diabetic NephropathyDiabetic nephropathy is a disease of the kidney glomerulus, which is caused by high blood sugar. When diabetes damages kidneys, which contain millions of tiny blood vessel clusters (glomeruli) that filter waste from the...

2014-05-05 23:11:26

As cases increase, national network of attorneys continues to offer no-cost consultations in connection with FDA's announcement that safety of testosterone treatments is under review. San Diego, CA (PRWEB) May 05, 2014 http://www.resource4thepeople.com/defectivedrugs/testosteronetreatments-lawsuits.html Resource4thePeople announced today the latest legal developments for consumers following lawsuits alleging that patients have suffered heart attacks and strokes from testosterone...

2014-04-29 23:16:34

AndroGel lawsuits Mount Against AbbVie Inc. As a Louisiana Man's Complaint Alleges He Suffered A Stroke Due to Low Testosterone Therapy Medication Columbus, OH (PRWEB) April 29, 2014 A new AndroGel lawsuit has been filed against AbbVie Inc. and Abbott Laboratories on behalf of a Louisiana man who alleged he suffered a stroke due to the low testosterone therapy medication. The attorneys at Wright & Schulte LLC note that this Androgel lawsuit comes as plaintiffs in other lawsuits...

2014-04-25 08:27:21

- Reports First-Quarter Adjusted EPS of $0.71, Up 4.4 Percent and Above Previous Guidance Range of $0.67 to $0.69 (Reports GAAP EPS of $0.61) NORTH CHICAGO, Ill., April 25, 2014 /PRNewswire/ -- AbbVie (NYSE:ABBV) announced financial results for the first quarter ended March 31, 2014. "AbbVie delivered strong first-quarter results, with sales and earnings per share above our original guidance, significant margin expansion, and increased R&D and SG&A investment to support our existing...


Word of the Day
tesla
  • The unit of magnetic flux density in the International System of Units, equal to the magnitude of the magnetic field vector necessary to produce a force of one newton on a charge of one coulomb moving perpendicular to the direction of the magnetic field vector with a velocity of one meter per second. It is equivalent to one weber per square meter.
This word is named for Nikola Tesla, the inventor, engineer, and futurist.